Clinical features and outcomes of XXXX with @entity344 : a single-center experience.

@entity1 @entity353 @entity2783 @entity294 @entity448 @entity344 @entity1582 @entity1129 @entity1349 @entity1209
BACKGROUND/AIMS: The gastrointestinal (GI) tract often becomes involved in @entity1 with @entity1582 . As few @entity344 data have been reported, we describe the clinical features and outcomes of @entity1 with pathologically proven @entity344 . METHODS: We identified 155 @entity1 diagnosed with @entity1582 between April 1995 and April 2013. Twenty-four @entity1 (15.5%) were diagnosed with @entity344 using associated symptoms, and the diagnoses were confirmed by direct biopsy. RESULTS: Among the 24 @entity1 , 20 (83.3%) had @entity2783 ( @entity2783 ), three (12.5%) had @entity1129 , and one (4.2%) had transthyretin-related @entity2783 . Their median age was 57 years (range, 37 to 72), and 10 @entity1 were female (41.7%). The most common symptoms of @entity344 were @entity294 (11 @entity1 , 45.8%), followed by @entity448 (nine @entity1 , 37.5%), @entity353 , and @entity1209 (seven @entity1 , 29.2%). The histologically confirmed GI tract site in @entity2783 was the stomach in 11 @entity1 (55.0%), the colon in nine (45.0%), the rectum in seven (35.0%), and the small bowel in one (5.0%). @entity1 with @entity344 had a greater frequency of organ involvement (p = 0.014). Median @entity1349 ( @entity1349 ) in @entity1 with @entity344 was shorter (7.95 months; range, 0.3 to 40.54) than in those without @entity344 (15.84 months; range, 0.0 to 114.53; p = 0.069) in a univariate analysis. A multivariate analysis of prognostic factors for @entity2783 revealed that @entity344 was not a significant predictor of @entity1349 (p = 0.447). CONCLUSIONS: The prognosis of @entity1 with @entity2783 was poorer than those without @entity344 , and they presented with more organ involvement and more advanced disease than those without organ involvement.
